Effect of systemic nitric oxide synthase inhibition on arterial stiffness in humans

Stiffening of large elastic arteries impairs the buffering function of the arterial system and contributes to cardiovascular disease. The aim of this study was to determine whether endothelium-derived nitric oxide (NO) modulates the stiffness of large elastic arteries in humans. Seven apparently healthy adults (60 +/- 3 years, 2 males and 5 females) underwent systemic a-adrenergic blockade (phentolamine) and systemic NO synthase inhibition using N-G-Monomethyl-L-arginine (L-NMMA) in sequence. Phentolamine was given first to isolate contribution of NO to arterial stiffness by preventing reflex changes in sympathetic tone that result from systemic NO synthase inhibition, and also to compare arterial stiffness at a similar mean arterial pressure. Mean arterial blood pressure decreased (p<0.05) after phentolamine infusion but returned to baseline levels after L-NMMA infusion. The carotid beta-stiffness index (via simultaneous ultrasound and applanation tonometry on the common carotid artery) did not change after the restraint of systemic alpha-adrenergic nerve activity (9.8 +/- 1.2 vs. 9.1 +/- 1.1 U) but increased (p<0.05) after NO synthase inhibition (12.6 +/- 2.0 U). These results suggest that NO appears to modulate central arterial stiffness in humans.